Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Strategic enterprise risk management and operational resilience in China’s pharmaceutical industry: A comparative analysis

This paper is a comparative research paper on Sinopharm and Kangtai Biological during COVID-19 to determine the effective enterprise risk management (ERM) in the companies during the pandemic. This study aims to analyse how ownership structure, regulatory support, and financial stability contribute to the effectiveness...

Xing Su, S. C. Ong · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.